Raymond James & Associates Abiomed Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$242.49 - $301.46 $501,226 - $623,117	-2,067 Reduced 70.04%	884 $217,000
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $298,441 - $449,713	1,328 Added 81.82%	2,951 $730,000
Q1 2022 May 11, 2022	SELL	$277.25 - $366.29 $276,418 - $365,191	-997 Reduced 38.05%	1,623 $538,000
Q4 2021 Feb 08, 2022	SELL	$300.63 - $371.35 $253,731 - $313,419	-844 Reduced 24.36%	2,620 $941,000
Q3 2021 Nov 02, 2021	SELL	$310.19 - $376.2 $37,843 - $45,896	-122 Reduced 3.4%	3,464 $1.13 Million
Q2 2021 Aug 11, 2021	SELL	$262.71 - $351.17 $1.24 Million - $1.65 Million	-4,704 Reduced 56.74%	3,586 $1.12 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $375,698 - $466,640	1,314 Added 18.84%	8,290 $2.64 Million
Q4 2020 Feb 12, 2021	SELL	$251.88 - $324.2 $68,511 - $88,182	-272 Reduced 3.75%	6,976 $2.26 Million
Q3 2020 Nov 04, 2020	BUY	$255.22 - $317.0 $391,507 - $486,278	1,534 Added 26.85%	7,248 $2.01 Million
Q2 2020 Jul 28, 2020	BUY	$141.4 - $257.09 $109,302 - $198,730	773 Added 15.64%	5,714 $1.38 Million
Q1 2020 Apr 21, 2020	SELL	$130.51 - $196.01 $557,799 - $837,746	-4,274 Reduced 46.38%	4,941 $717,000
Q4 2019 Feb 12, 2020	SELL	$159.31 - $223.54 $4.17 Million - $5.85 Million	-26,179 Reduced 73.96%	9,215 $1.57 Million
Q3 2019 Nov 07, 2019	SELL	$175.89 - $279.23 $407,537 - $646,975	-2,317 Reduced 6.14%	35,394 $6.3 Million
Q2 2019 Aug 06, 2019	SELL	$250.96 - $284.94 $601,049 - $682,431	-2,395 Reduced 5.97%	37,711 $9.82 Million
Q1 2019 May 06, 2019	BUY	$276.39 - $362.25 $2.31 Million - $3.03 Million	8,368 Added 26.37%	40,106 $11.5 Million
Q4 2018 Feb 11, 2019	SELL	$281.08 - $444.25 $2.88 Million - $4.55 Million	-10,242 Reduced 24.4%	31,738 $10.3 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $5.89 Million - $7.47 Million	16,606 Added 65.44%	41,980 $18.9 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $1.15 Million - $1.85 Million	-4,146 Reduced 14.04%	25,374 $10.4 Million
Q1 2018 May 14, 2018	BUY	$192.49 - $295.85 $1.91 Million - $2.93 Million	9,913 Added 50.56%	29,520 $8.59 Million
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $199,160 - $235,693	1,180 Added 6.4%	19,607 $3.68 Million
Q3 2017 Nov 13, 2017	BUY	$145.39 - $168.6 $822,325 - $953,601	5,656 Added 44.29%	18,427 $3.11 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,771	12,771 $1.83 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account